Recombinant Enterococcus faecalis Diaminopimelate epimerase (dapF)

Shipped with Ice Packs
In Stock

Description

Introduction to Diaminopimelate Epimerase (dapF)

Diaminopimelate epimerase, encoded by the gene dapF, is an enzyme crucial for the biosynthesis of L-lysine and peptidoglycan in bacteria. It catalyzes the conversion of L,L-diaminopimelate (L,L-DAP) to meso-diaminopimelate (meso-DAP), a key step in the biosynthetic pathway from aspartate to lysine . While specific information on recombinant Enterococcus faecalis diaminopimelate epimerase is limited, understanding the general properties and functions of diaminopimelate epimerase can provide valuable insights.

Structure and Function of Diaminopimelate Epimerase

Diaminopimelate epimerase is a monomeric protein, typically around 30 kDa, consisting of two domains that form a barrel structure around a central helix. The active site is located at the interface of these domains and contains conserved cysteine residues essential for catalysis . The enzyme operates as a PLP-independent amino acid racemase, facilitating the epimerization without requiring pyridoxal phosphate as a cofactor .

Role in L-Lysine Biosynthesis

In the biosynthesis of L-lysine, diaminopimelate epimerase plays a pivotal role by converting L,L-DAP into meso-DAP, which is then further processed to L-lysine . This pathway is critical in bacteria like Escherichia coli and Corynebacterium glutamicum, where L-lysine is an essential amino acid .

Potential Applications

Diaminopimelate epimerase is considered a potential target for antibacterial drug development due to its essential role in bacterial cell wall synthesis . Additionally, its unique catalytic properties make it an interesting subject for studies on enzyme promiscuity and evolution .

Research Findings and Data

While specific data on recombinant Enterococcus faecalis diaminopimelate epimerase is not readily available, studies on other bacterial species provide valuable insights into its function and potential applications.

Table: Comparison of Diaminopimelate Epimerase Across Different Bacterial Species

Bacterial SpeciesMolecular Weight (kDa)FunctionCofactor Requirement
Escherichia coli~30Epimerization of L,L-DAP to meso-DAPPLP-independent
Corynebacterium glutamicum~30Epimerization of L,L-DAP to meso-DAPPLP-independent
Chlamydia trachomatis~32Bifunctional: epimerase and glutamate racemasePLP-dependent for racemase activity

References PubMed: Diaminopimelate epimerase (DapF) from Corynebacterium glutamicum. Wikipedia: Diaminopimelate epimerase. Journal of Bacteriology: Chlamydia trachomatis dapF Encodes a Bifunctional Enzyme. UniProt: Diaminopimelate epimerase from Escherichia coli. InterPro: Diaminopimelate epimerase (IPR001653).

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please indicate this in your order notes; we will accommodate your request to the best of our ability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All protein shipments include standard blue ice packs. Dry ice shipping requires prior arrangement and incurs an additional fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag type, please inform us, and we will prioritize its development.
Synonyms
dapF; EF_0464; Diaminopimelate epimerase; DAP epimerase; EC 5.1.1.7; PLP-independent amino acid racemase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-326
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Enterococcus faecalis (strain ATCC 700802 / V583)
Target Names
dapF
Target Protein Sequence
MNVMMQKVHG SENDFFLLDE TQFERSLTAE EIEQLRIQLC SRETGLLAGA DGLLLVGEGT HGTSNARMRV INSDGSEASM CGNGLRTVAR YLAEKNQEKS FTVETMFADL KVRQAPNLAE EVATYQVEIS PVSFEAVTIP MHLGVQTLID EIVPALSNTI RFTAVAVPNP HLVAFVDHET LNGPEFERIA TYVNNENPYF PEGINVSFVE ILGKNQLFVR TYERGVGFTS ACGTAMCASS LLYTLLKDGV FYEEITVKNT GGMVKTVVHE TSDGSYWMEL IGNATITHLI EGSLTDLLNG AFEKITITET NEQKHYQEFL QTLSQK
Uniprot No.

Target Background

Function
Diaminopimelate epimerase (DapF) catalyzes the stereoinversion of LL-2,6-diaminoheptanedioate (L,L-DAP) to meso-diaminoheptanedioate (meso-DAP). Meso-DAP serves as a precursor for L-lysine and a crucial component of bacterial peptidoglycan.
Database Links

KEGG: efa:EF0464

STRING: 226185.EF0464

Protein Families
Diaminopimelate epimerase family
Subcellular Location
Cytoplasm.

Q&A

What is the biological function of Enterococcus faecalis diaminopimelate epimerase (DapF)?

Diaminopimelate epimerase (DapF) in E. faecalis is a crucial enzyme involved in the metabolism of lysine and meso-diaminopimelate (meso-DAP). It specifically catalyzes the isomerization of L,L-diaminopimelate (L,L-DAP) to meso-DAP in a pathway that converts aspartate to lysine . This enzymatic conversion plays vital roles in:

  • Peptidoglycan biosynthesis, which forms the bacterial cell wall structure

  • Synthesis of essential housekeeping proteins

  • Production of bacterial virulence factors that contribute to pathogenicity
    The enzyme functions in a pathway where it specifically catalyzes the stereoconversion between isomers, representing a critical point in lysine metabolism that is absent in mammals, making it an attractive antimicrobial target .

How does the mechanism of DapF differ from other bacterial epimerases?

DapF employs a distinctive two-base mechanism that distinguishes it from many other bacterial epimerases:

  • The enzyme utilizes two catalytic cysteine residues in its active site that are critical for function

  • These cysteines operate in a concerted fashion where one abstracts a proton from the substrate's α-carbon while the other donates a proton to the opposite face

  • Unlike many epimerases that require NAD+ as a cofactor, DapF operates without external cofactors

  • The enzyme undergoes significant conformational changes during catalysis, transitioning between open and closed states
    Studies on related DapF enzymes, such as in Corynebacterium glutamicum, reveal that the enzyme's activity is regulated through redox-sensitive cysteine residues that can form a disulfide bond under oxidizing conditions, rendering the enzyme inactive .

What experimental approaches are used to assay DapF activity?

Several methodological approaches can be employed to assess DapF activity:

  • Chromatographic analysis:

    • HPLC separation of L,L-DAP and meso-DAP followed by quantification

    • Gas chromatography after appropriate derivatization

  • Spectrophotometric methods:

    • Coupled enzymatic assays that generate detectable products

    • p-Nitrophenyl-based substrates that release chromogenic products upon reaction

  • Radiometric assays:

    • Using radiolabeled substrates to track conversion

    • Separation of radiolabeled products through various techniques

  • Circular dichroism:

    • Monitoring changes in optical activity during stereochemical conversion
      An example assay procedure involves:

  • Buffer: 0.1 M MES, pH 6.0

  • Substrate: Synthetic L,L-DAP at 0.1-1.0 mM

  • Enzyme concentration: 0.05-1.0 μg per reaction

  • Temperature: 30-37°C (physiological range)

  • Reaction time: 5-30 minutes depending on enzyme concentration

  • Detection method: HPLC analysis or coupled enzyme assay

How does the structural comparison between E. faecalis DapF and other bacterial DapF enzymes inform drug design?

Comparative structural analysis of DapF enzymes from different bacterial species reveals important insights for targeted drug development:

What role does DapF play in E. faecalis antibiotic resistance mechanisms?

While DapF itself is not directly involved in conferring antibiotic resistance, its function intersects with resistance mechanisms in several important ways:

  • Cell wall integrity: By providing meso-DAP for peptidoglycan synthesis, DapF contributes to cell wall integrity, which is crucial for withstanding cell wall-targeting antibiotics

  • Stress response: DapF activity may be modulated as part of bacterial stress responses to antibiotics, particularly those affecting cell envelope integrity

  • Biofilm formation: E. faecalis is known to form biofilms on medical devices, enhancing antibiotic resistance. The peptidoglycan layer, which depends on DapF activity, plays a role in biofilm architecture

  • Metabolic adaptation: Changes in DapF expression or activity may occur during metabolic adaptations that accompany the development of resistance to certain antibiotics
    The study of daptomycin resistance in E. faecalis has revealed mutations in genes encoding proteins involved in cell envelope stress response and phospholipid metabolism, highlighting the importance of cell envelope components in resistance mechanisms . While not directly implicated, DapF's role in cell wall synthesis positions it at a critical junction in cellular processes related to antibiotic resistance.

How can redox conditions impact the expression and purification of recombinant E. faecalis DapF?

Redox conditions critically influence both the expression and purification of recombinant E. faecalis DapF:

  • Expression considerations:

    • Cytoplasmic expression in E. coli provides a reducing environment favorable for DapF activity

    • Co-expression with thioredoxin or glutaredoxin can enhance proper folding

    • Lower temperature (16-20°C) expression reduces formation of insoluble aggregates

    • IPTG concentration should be optimized to balance yield and proper folding

  • Purification strategies:

    • All buffers should contain reducing agents (1-5 mM DTT or 5-10 mM β-mercaptoethanol)

    • Purification under aerobic conditions without reducing agents may result in inactive enzyme

    • Arginine (50-100 mM) in purification buffers can enhance protein stability

    • pH optimization (typically 6.0-7.5) is crucial for maintaining enzymatic activity

  • Storage recommendations:

    • Addition of glycerol (10-20%) prevents freeze-thaw damage

    • Storage buffers must contain reducing agents

    • Flash-freezing in liquid nitrogen preserves activity better than slow freezing

    • Carrier-free preparations (without BSA) require special attention to buffer optimization
      The redox-sensitive nature of the catalytic cysteines in DapF means that oxidizing conditions can lead to disulfide bond formation, resulting in conformational changes that inactivate the enzyme .

What experimental approaches can determine the kinetic parameters of substrate binding and catalysis for E. faecalis DapF?

Comprehensive kinetic analysis of E. faecalis DapF requires multiple experimental approaches:

  • Steady-state kinetics:

    • Vary substrate (L,L-DAP) concentration (0.01-5 mM range)

    • Measure initial velocities at each concentration

    • Plot data using Michaelis-Menten, Lineweaver-Burk, or Eadie-Hofstee methods

    • Determine Km, Vmax, and kcat parameters

  • Pre-steady-state kinetics:

    • Stopped-flow spectroscopy to capture rapid changes

    • Quenched-flow techniques to analyze reaction intermediates

    • Determination of rate constants for individual steps in the catalytic cycle

  • Temperature and pH effects:

    • Measure activity across pH range (5.0-9.0)

    • Determine temperature optima and activation energy

    • Calculate thermodynamic parameters (ΔH, ΔS, ΔG)

  • Inhibition studies:

    • Competitive vs. non-competitive inhibition analysis

    • IC50 and Ki determination for potential inhibitors

    • Time-dependent inhibition analysis for slow-binding inhibitors

  • Substrate specificity analysis:

    • Test substrate analogs with modifications at different positions

    • Determine specificity constants (kcat/Km) for each substrate variant

    • Map substrate recognition elements through systematic variations
      These approaches can be complemented with structural and computational methods to develop a comprehensive understanding of the catalytic mechanism .

How should one design experiments to identify potential inhibitors of E. faecalis DapF?

A comprehensive inhibitor discovery pipeline for E. faecalis DapF should include:

  • Initial screening approaches:

    • High-throughput enzymatic assays using recombinant DapF

    • Fragment-based screening using thermal shift assays

    • Virtual screening based on homology models or crystal structures

    • Repurposing screens of clinically approved compounds

  • Validation and characterization:

    • Dose-response curves to determine IC50 values

    • Mode of inhibition studies (competitive, non-competitive, uncompetitive)

    • Reversibility assessment through dilution experiments

    • Thermal shift assays to confirm direct binding

  • Selectivity profiling:

    • Counter-screening against DapF from other bacterial species

    • Testing against human enzymes to assess potential toxicity

    • Evaluation against a panel of related bacterial epimerases

  • Structure-activity relationship studies:

    • Systematic modification of hit compounds

    • Crystallography or NMR studies of enzyme-inhibitor complexes

    • Computational docking to guide optimization

  • Cellular validation:

    • Growth inhibition assays with E. faecalis

    • Metabolic labeling to confirm on-target activity

    • Combination studies with existing antibiotics

    • Biofilm inhibition assays
      This multi-tiered approach ensures that identified inhibitors have the desired potency, selectivity, and cellular activity profiles required for further development .

What considerations are important when analyzing the impact of site-directed mutagenesis on E. faecalis DapF activity?

Site-directed mutagenesis studies of E. faecalis DapF require careful experimental design and interpretation:

  • Selection of residues for mutation:

    • Catalytic residues (cysteine pair in the active site)

    • Substrate binding residues identified through structural analysis

    • Residues involved in domain movement and conformational changes

    • Potentially important second-shell residues that support the active site

  • Types of mutations to consider:

    • Conservative substitutions (e.g., Cys→Ser) to maintain similar geometry

    • Charge-altering mutations to assess electrostatic contributions

    • Size-altering mutations to probe spatial requirements

    • Alanine scanning to identify essential sidechains

  • Activity analysis protocols:

    • Standardized expression and purification protocols for all variants

    • Full kinetic characterization (Km, kcat, kcat/Km) for each mutant

    • pH-rate profiles to detect changes in acid-base properties

    • Thermal stability analysis to distinguish catalytic from structural effects

  • Structural confirmation:

    • Circular dichroism to confirm proper folding

    • Size exclusion chromatography to verify oligomeric state

    • Crystallography when possible to visualize structural changes

  • Data interpretation challenges:

    • Distinguishing between effects on substrate binding versus catalysis

    • Accounting for potential long-range conformational effects

    • Considering combinatorial effects when multiple residues are involved

    • Correlating results with computational predictions
      By systematically analyzing mutants, researchers can develop a detailed understanding of structure-function relationships in E. faecalis DapF .

How can computational models be validated and refined for studying E. faecalis DapF substrate specificity?

Validation and refinement of computational models for E. faecalis DapF require an iterative approach combining in silico and experimental methods:

  • Initial model validation:

    • Homology model quality assessment using PROCHECK, VERIFY3D

    • Ramachandran plot analysis to identify unfavorable conformations

    • Analysis of binding site geometry compared to template structures

    • Energy minimization to relieve unfavorable contacts

  • Experimental validation techniques:

    • Site-directed mutagenesis of predicted key residues

    • Binding studies with substrate analogs to test predicted interactions

    • Thermal shift assays to verify ligand-induced stabilization

    • Crystal structure determination when possible

  • Model refinement strategies:

    • Molecular dynamics simulations to sample conformational space

    • QM/MM calculations to refine active site geometry

    • Incorporation of experimental data as constraints

    • Ensemble docking to account for protein flexibility

  • Substrate specificity predictions:

    • Docking of substrate analogs to predict binding affinity trends

    • Free energy perturbation calculations for quantitative binding estimates

    • Correlation of computational predictions with experimental specificity data

  • Iterative improvement:

    • Systematic refinement based on experimental feedback

    • Implementation of machine learning approaches for prediction improvement

    • Development of specialized force field parameters for the DapF system
      This integrated approach ensures that computational models accurately reflect the structural and functional properties of E. faecalis DapF, providing reliable insights into substrate specificity .

What methodologies can effectively measure the impact of redox conditions on E. faecalis DapF structure and function?

A comprehensive assessment of redox effects on E. faecalis DapF requires multiple complementary approaches:

  • Activity assays under controlled redox conditions:

    • Enzymatic assays in buffers with defined redox potentials

    • Activity measurements in the presence of various concentrations of reducing agents

    • Time-dependent inactivation under oxidizing conditions

    • Recovery of activity after reintroduction of reducing agents

  • Structural analysis techniques:

    • Mass spectrometry to detect disulfide bond formation

    • Limited proteolysis to probe conformational changes

    • Circular dichroism to monitor secondary structure alterations

    • Intrinsic tryptophan fluorescence to detect tertiary structure changes

  • Thiol-specific analytical methods:

    • Ellman's reagent (DTNB) assay to quantify free thiols

    • Differential alkylation with iodoacetamide followed by mass spectrometry

    • Isothermal titration calorimetry with thiol-reactive compounds

    • Redox potential determination using glutathione redox buffers

  • Direct observation of conformational states:

    • Crystal structures under oxidizing and reducing conditions

    • Hydrogen-deuterium exchange mass spectrometry to map conformational changes

    • Small-angle X-ray scattering to monitor domain movements

    • Single-molecule FRET to observe conformational dynamics

  • Correlation with physiological conditions:

    • Activity assays at physiologically relevant redox potentials

    • Effects of oxidative stress mimetics on enzyme function

    • Comparison with bacterial cytoplasmic redox conditions
      These methodologies would reveal how redox conditions influence the structure-function relationship of E. faecalis DapF, providing insights into potential regulatory mechanisms and opportunities for inhibitor design .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.